| scholarly article | Q13442814 |
| P50 | author | Henric Ek Olofsson | Q92921494 |
| P2093 | author name string | E Englund | |
| P2860 | cites work | Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 | Q24316075 |
| Cerebrovascular disease in ageing and Alzheimer's disease | Q26771852 | ||
| Neuropathological stageing of Alzheimer-related changes | Q27860862 | ||
| Mechanisms of angiogenesis | Q29547485 | ||
| The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease | Q29614948 | ||
| Chronic cerebral hypoperfusion induces vascular plasticity and hemodynamics but also neuronal degeneration and cognitive impairment | Q30927208 | ||
| Alterations of the cerebral cortex in sporadic small vessel disease: A systematic review of in vivo MRI data | Q31038247 | ||
| Mechanisms of angiogenesis in the brain | Q33602917 | ||
| Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration | Q33685317 | ||
| Vascular pathology in the aged human brain | Q33699436 | ||
| Clinical features of leuko-araiosis. | Q33735250 | ||
| Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease | Q33955976 | ||
| Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update | Q34020227 | ||
| Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis. | Q34109028 | ||
| Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain | Q34282041 | ||
| Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease | Q34309107 | ||
| Primary age-related tauopathy (PART): a common pathology associated with human aging | Q34445021 | ||
| Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry | Q34556945 | ||
| National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease | Q34635272 | ||
| White matter pathology and disconnection in the frontal lobe in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). | Q34805975 | ||
| Cerebral Hypoperfusion and the Energy Deficit in Alzheimer's Disease | Q48663991 | ||
| Pyramidal neurons of the prefrontal cortex in post-stroke, vascular and other ageing-related dementias | Q48689999 | ||
| VEGF and flt. Expression time kinetics in rat brain infarct | Q48910869 | ||
| Clinicopathological concordance in dementia diagnostics. | Q51818113 | ||
| The microvascular system in ischemic cortical lesions | Q57189463 | ||
| Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2 | Q59200918 | ||
| Role of angiogenesis in patients with cerebral ischemic stroke | Q71643306 | ||
| Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia | Q77530408 | ||
| Opposite effects of beta amyloid on endothelial cell survival: role of fibroblast growth factor-2 (FGF-2) | Q82273342 | ||
| Cerebral pattern of pro- and anti-inflammatory cytokines in dementias | Q35196326 | ||
| Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications | Q35482194 | ||
| Neuroanatomical localisation and clinical correlates of white matter lesions in the elderly | Q35482688 | ||
| Microglia: scapegoat, saboteur, or something else? | Q35606301 | ||
| Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia | Q35809808 | ||
| Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy | Q35960407 | ||
| Role of inflammatory mediators in angiogenesis. | Q36048112 | ||
| Orthostatic Hypotension and the Long-Term Risk of Dementia: A Population-Based Study | Q36160395 | ||
| Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease | Q36491332 | ||
| Mechanisms of arteriogenesis | Q37237370 | ||
| Evidence of angiogenic vessels in Alzheimer's disease | Q37365919 | ||
| Angiogenesis after cerebral ischemia | Q37368002 | ||
| Innate immune activation in neurodegenerative disease | Q38223011 | ||
| The Vascular Impairment of Cognition Classification Consensus Study | Q38783436 | ||
| CADASIL accelerated by acute hypotension: Arterial and venous contribution to leukoaraiosis | Q38959334 | ||
| Inhibition of angiogenesis by Abeta peptides | Q40526893 | ||
| Elevated circulating tumor necrosis factor levels in Alzheimer's disease | Q41145103 | ||
| The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease | Q41215183 | ||
| Vascular Endothelial Growth Factor Expression and Angiogenesis Induced by Chronic Cerebral Hypoperfusion in Rat Brain | Q42450867 | ||
| Identification of Alzheimer and vascular lesion thresholds for mixed dementia | Q42518976 | ||
| Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia | Q43937474 | ||
| Neovasculature and blood-brain barrier in ischemic brain infarct | Q44563191 | ||
| Ischaemic brain damage after cardiac arrest and induced hypothermia--a systematic description of selective eosinophilic neuronal death. A neuropathologic study of 23 patients | Q44926632 | ||
| Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease | Q47659314 | ||
| Vascular endothelial growth factor expression in transient focal cerebral ischemia in the rat. | Q47772427 | ||
| The pathology and pathophysiology of vascular dementia. | Q47898593 | ||
| Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct | Q48182992 | ||
| Expression of vascular endothelial growth factor mRNA following transient forebrain ischemia in rats | Q48211634 | ||
| Vascular endothelial growth factor and its receptor, KDR, in human brain tissue after ischemic stroke | Q48231408 | ||
| Beta amyloid angiogenic activity in vitro and in vivo | Q48255154 | ||
| Imaging angiogenesis using 68Ga-NOTA-PRGD2 positron emission tomography/computed tomography in patients with severe intracranial atherosclerotic disease | Q48273386 | ||
| Relationship between vascular factors and white matter low attenuation of the brain | Q48306860 | ||
| Incident subcortical infarcts induce focal thinning in connected cortical regions | Q48341611 | ||
| Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia | Q48363690 | ||
| A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. | Q48367859 | ||
| Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies. | Q48392021 | ||
| Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. | Q48395559 | ||
| Neuropathology of white matter changes in Alzheimer's disease and vascular dementia. | Q48406159 | ||
| Alzheimer's beta-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2. | Q48437757 | ||
| Cerebral amyloid angiopathy, white matter lesions and Alzheimer encephalopathy - a histopathological assessment | Q48490812 | ||
| Progressive expression of vascular endothelial growth factor (VEGF) and angiogenesis after chronic ischemic hypoperfusion in rat. | Q48557088 | ||
| Phases of A beta-deposition in the human brain and its relevance for the development of AD. | Q48567985 | ||
| White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury | Q48575517 | ||
| Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease | Q48607839 | ||
| Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats | Q48613015 | ||
| P433 | issue | 6 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| vascular dementia | Q583908 | ||
| frontotemporal lobar degeneration | Q18579 | ||
| angiogenesis | Q539568 | ||
| P304 | page(s) | 557-569 | |
| P577 | publication date | 2019-05-09 | |
| P1433 | published in | Neuropathology and Applied Neurobiology | Q7002494 |
| P1476 | title | A cortical microvascular structure in vascular dementia, Alzheimer's disease, frontotemporal lobar degeneration and nondemented controls: a sign of angiogenesis due to brain ischaemia? | |
| P478 | volume | 45 |
| Q92454775 | Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy | cites work | P2860 |
Search more.